Stilla and Promega Announce Co-Marketing Agreement to Offer Complete Digital PCR Workflow Solution BOSTON--Stilla Technologies, the multiplex digital PCR company, and Promega Corporation today announced a co-marketing agreement that combines sample preparation with the latest Maxwell® systems and digital PCR on the six-color naica® system. With this partnership, the companies will offer an [...]
Stilla Technologies Expands EMEA Footprint with New Distribution Partnerships BOSTON & PARIS--(BUSINESS WIRE)--Stilla Technologies, the multiplex digital PCR company, today announced it has entered into agreements with 12 distributors throughout EMEA: LABGENE Scientific (Switzerland), CARLO ERBA Reagents (Italy), Bonsai Lab (Portugal and Spain), SEM (Turkey), Explorea (Czech Republic, Slovakia, Hungary), Biodynamics (Greece), AH diagnostics [...]
Stilla Technologies Secures Financing of More Than €31 Million Adding Casdin Capital and the European Investment Bank to Existing Investors PARIS & BOSTON--(BUSINESS WIRE)--Stilla Technologies, the multiplex digital PCR company, today announced it has raised €31.3 million in the form of €11.3 million of convertible bonds and €20 million in loan financing. In addition [...]
Leading Researchers Present 24-Plex Digital PCR Assay and Novel Multiplex Applications Uniquely Enabled by Stilla’s 6-Color naica® system Industry’s First 6-Color Digital PCR System Answers Market Needs for Higher Performance and Multiplexing Technology BOSTON and PARIS, October 15, 2021, – Stilla Technologies, the multiplex digital PCR company, joined researchers from SAGA Diagnostics [...]
Stilla Technologies Launches Access Program for Industry’s First Six-Color Digital PCR System New dPCR Platform Offers High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Environmental Testing BOSTON and PARIS, July 28, 2021, – Stilla Technologies, the company innovating the next generation [...]
Stilla Technologies Strengthens Executive Team with Appointment of Matthew Grow, PhD, to Vice President Global Marketing and Commercial Operations Life Sciences Veteran to Lead Commercialization of Disruptive Digital PCR Technology for a Broad Range of Basic Research and Clinical Applications BOSTON and PARIS, June 30, 2021, – Stilla Technologies, the company innovating the [...]
June the 30th 2021 - (8 AM PDT | 11 AM EDT | 4 PM BST | 5 PM CEST), Liquid Biopsy Detection of EGFR Mutations in NSCLC Patients Before and After Osimertinib Therapy by Evi Lianidou (University of Athens) REGISTER HERE Speakers’s Bio Evi Lianidou, PhD Professor of Analytical Chemistry, Clinical [...]
March the 11th 2021 - (7 AM PDT | 10 AM EDT | 3 PM BST | 4 PM CEST), Advancing dPCR for various applications This webinar will cover how we are improving the ways we approach dPCR for various applications, and how we are addressing the challenges associated with the use of this [...]
Stilla expands leadership team to drive next phase of global commercial growth; appoints Philippe Mourere as President BOSTON, MA and PARIS, FRANCE - February 2, 2021 - Stilla Technologies is pleased to announce the appointment of Mr. Philippe Mourere as its new Chief Executive Officer. Former CEO and Founder Dr. Rémi Dangla has been [...]
February the 3rd 2021 - (8 AM PDT | 11 AM EDT | 4 PM BST | 5 PM CEST), Design and optimize high multiplexing digital PCR assays with the naica® system by Erik Wendlandt (Integrated DNA Technologies) & Kimberley Gutierrez (Stilla Technologies) Speakers’s Bio Erik Wendlandt Field Applications Scientist Integrated DNA Technologies [...]